Menopause has been ignored for too long
Menopause has been ignored for too long

Menopause has been ignored for too long

Find out why Astellas is speaking up and shining a light on the symptoms and experiences of people impacted by menopause this World Menopause Day.

View more
Financial Results

Financial Results for Q2/FY2023

We announced our financial results for Q2/FY2023 on November 1st. Presentation material, video, and meeting script are available.

Read more
Integrated Report 2023

Integrated Report 2023

Please check the latest Integrated Report. (former Annual Report)

Read more
From the CEO

From the CEO

I will make every effort to navigate Astellas with speed and a sense of urgency that “our patients are waiting.”

Read more
Latest News
General News
Astellas Updates “Contact for Potential Acquisition of Astellas’ R&D Programs” Section on its Corporate Website
Press Releases
FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Press Releases
Astellas’ Fezolinetant Reduces Frequency and Severity of VMS Associated with Menopause in Women Considered Unsuitable for Hormone Therapy
EXPLORE ALL NEWS
About us

About us

Astellas aims to stand on the forefront of healthcare change to turn innovative science into VALUE for patients.

Read more
R & D Strategy

R & D Strategy

Astellas’ Focus Area approach supports our commitment to continuous innovation and the creation of innovative therapies that directly address the underlying causes of disease.

Read more
Astellas and Sustainability

Sustainability

We are developing a sustainable society by leveraging Astellas’ strengths and capabilities.

Read more


 

Partnering with Astellas
Partnering with Astellas

Partnering with Astellas

We are actively seeking collaboration opportunities with external partners.

Read More
Investor Relations

Investor Relations

Read More
LinkedIn

Astellas Pharma’s official LinkedIn

We share the latest information and topics.

Follow us

Modern Slavery Act 2015

Contact for Potential Acquisition of Astellas’ R＆D programs.